Abridge

village in the United Kingdom

Positive
Negative

Entity sentiment

Share opinion
Tip: Add insight, not just a reaction
Abridge secures $316 million to expand AI in healthcare
technology Jun 11, 2026, 2:00 AM
Abridge secures $316 million to expand AI in healthcare
  • Abridge has developed an AI-native clinician intelligence platform that documents patient-clinician conversations.
  • The startup has raised approximately $1.1 billion, with a recent $316 million Series E extension in April 2026.
  • The partnership with Eli Lilly aims to enhance Abridge's capabilities in life sciences and accelerate clinical trial enrollment.
100
Abridge for Nurses launches AI tool across 250 health systems
technology May 7, 2026, 1:17 AM
Abridge for Nurses launches AI tool across 250 health systems
  • Abridge for Nurses has launched its AI documentation tool across over 250 health systems in the United States.
  • The introduction follows two years of development involving pilots and nurse feedback to ensure usability.
  • The adoption of Abridge's tool aims to improve nursing workflows and patient understanding, despite challenges in implementation.
100
Twin Health patients overcome diabetes challenges more effectively than traditional care options
business Dec 18, 2025, 7:46 PM
Twin Health patients overcome diabetes challenges more effectively than traditional care options
  • Twin Health patients showed a marked improvement in stopping glucose-lowering medications compared to standard care patients.
  • Weight loss rates among Twin Health users were approximately double those of conventionally treated peers.
  • These findings suggest a pressing need for healthcare systems to consider innovative approaches to chronic disease management.
100
AI startups rapidly raise funding and soar in valuations
technology Nov 29, 2025, 1:00 AM
AI startups rapidly raise funding and soar in valuations
  • In 2025, many AI startups have raised multiple significant funding rounds, resulting in soaring valuations.
  • Well-known startups like Harvey and Cursor achieved remarkable valuations of $8 billion and $10 billion respectively.
  • This rapid funding environment raises concerns about the sustainability of high evaluations and the potential risks for investors.
300
2026 All rights reserved